Literature DB >> 11867215

Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development.

Jiachang Zhang1, Wen Li Liu, Delia C Tang, Ling Chen, Min Wang, Svetlana D Pack, Zhengping Zhuang, Griffin P Rodgers.   

Abstract

We have cloned a novel hematopoietic granulocyte colony-stimulating factor (G-CSF)-induced olfactomedin-related glycoprotein, termed hGC-1 (human G-CSF-stimulated clone-1). mRNA differential display was used in conjunction with a modified two-phase liquid culture system. Cultures were enriched for early precursors of erythroid, myeloid, and megakaryocytic lineages, which were isolated after induction with erythropoietin, G-CSF, and thrombopoietin, respectively. RNA from the enriched cells was subjected to differential display analysis to identify lineage-specific expressed genes. One clone specifically induced by G-CSF, hGC-1, was characterized. The 2861 bp cDNA clone of hGC-1 contained an open reading frame of 1530 nucleotides, translating into a protein of 510 amino acids with a signal peptide and six N-linked glycosylation motifs. The protein sequence of hGC-1 showed it to be a glycoprotein of the olfactomedin family, which includes olfactomedin, TIGR, Noelin-2 and latrophilin-1. Olfactomedin-like genes show characteristic tissue-restricted patterns of expression; the specific tissues expressing these genes differ among the family members. hGC-1 was strongly expressed in the prostate, small intestine, and colon, moderately expressed in the bone marrow and stomach, and not detectable in other tissues. In vitro translation and ex vivo expression showed hGC-1 to be an N-linked glycoprotein. The hGC-1 gene locus mapped to chromosome 13q14.3. Together, our findings indicate that hGC-1 is primarily expressed as an extracellular olfactomedin-related glycoprotein during normal myeloid-specific lineage differentiation, suggesting the possibility of a matrix-related function for hGC-1 in differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867215     DOI: 10.1016/s0378-1119(01)00763-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  54 in total

1.  Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.

Authors:  Wenli Liu; Ming Yan; Yueqin Liu; Ruihong Wang; Cuiling Li; Chuxia Deng; Aparna Singh; William G Coleman; Griffin P Rodgers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells.

Authors:  Kelli L VanDussen; Alexis J Carulli; Theresa M Keeley; Sanjeevkumar R Patel; Brent J Puthoff; Scott T Magness; Ivy T Tran; Ivan Maillard; Christian Siebel; Åsa Kolterud; Ann S Grosse; Deborah L Gumucio; Stephen A Ernst; Yu-Hwai Tsai; Peter J Dempsey; Linda C Samuelson
Journal:  Development       Date:  2011-12-21       Impact factor: 6.868

3.  Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.

Authors:  Wenli Liu; Hyun Woo Lee; Yueqin Liu; Ruihong Wang; Griffin P Rodgers
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

Review 4.  A molecular mechanism for glaucoma: endoplasmic reticulum stress and the unfolded protein response.

Authors:  Robert R H Anholt; Mary Anna Carbone
Journal:  Trends Mol Med       Date:  2013-07-19       Impact factor: 11.951

5.  Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling.

Authors:  Hellen Dassen; Chamindie Punyadeera; Bert Delvoux; Iris Schulkens; Claudia Marchetti; Rick Kamps; Jan Klomp; Fred Dijcks; Anton de Goeij; Thomas D'Hooghe; Cleophas Kyama; Antwan Ederveen; Gerard Dunselman; Patrick Groothuis; Andrea Romano
Journal:  Am J Pathol       Date:  2010-11       Impact factor: 4.307

6.  Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock.

Authors:  Matthew N Alder; Amy M Opoka; Patrick Lahni; David A Hildeman; Hector R Wong
Journal:  Crit Care Med       Date:  2017-04       Impact factor: 7.598

Review 7.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

8.  Olfactomedin 4 contributes to hydrogen peroxide-induced NADPH oxidase activation and apoptosis in mouse neutrophils.

Authors:  Wenli Liu; Yueqin Liu; Hongzhen Li; Griffin P Rodgers
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

9.  Myocilin promotes substrate adhesion, spreading and formation of focal contacts in podocytes and mesangial cells.

Authors:  Andreas Goldwich; Michael Scholz; Ernst R Tamm
Journal:  Histochem Cell Biol       Date:  2008-10-15       Impact factor: 4.304

10.  Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in mice.

Authors:  Wenli Liu; Ming Yan; Yueqin Liu; Kenneth R McLeish; William G Coleman; Griffin P Rodgers
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.